Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$10.53 USD
0.00 (0.00%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $10.58 +0.05 (0.47%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.50 |
Last EPS Surprise | -66.67% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.33 |
Next Year | 0.20 |
EPS (TTM) | -1.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 32.38M | 37.19M | 142.03M | 183.40M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 33.81M | 41.86M | 154.62M | 198.94M |
Low Estimate | 29.78M | 32.30M | 126.90M | 160.00M |
Year ago Sales | 26.89M | 28.13M | 116.88M | 142.03M |
Year over Year Growth Est. | 20.40% | 32.21% | 21.52% | 29.12% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.47 | -1.33 | 0.20 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.50 | -0.50 | -1.80 | -0.70 |
High Estimate | -0.30 | 0.00 | -0.50 | 1.00 |
Low Estimate | -0.50 | -0.90 | -1.80 | -0.70 |
Year ago EPS | -0.40 | -0.30 | -1.40 | -1.33 |
Year over Year Growth Est. | 7.50% | -56.67% | 5.00% | 115.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.47 | -1.33 | 0.20 |
7 Days Ago | -0.37 | -0.47 | -1.33 | 0.20 |
30 Days Ago | -0.37 | -0.47 | -1.33 | 0.20 |
60 Days Ago | -0.37 | -0.47 | -1.33 | 0.20 |
90 Days Ago | -0.27 | -0.67 | -0.90 | 0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.47 | -1.33 | 0.20 |
Zacks Consensus Estimate | -0.37 | -0.47 | -1.33 | 0.20 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | 0.00 | -0.30 | -0.40 | NA |
Estimate | -0.30 | -0.30 | -0.70 | -0.80 | NA |
Difference | -0.20 | 0.30 | 0.40 | 0.40 | 0.23 |
Surprise | -66.67% | 100.00% | 57.14% | 50.00% | 35.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more